|
|
Nevisense Used in Fundamental Skin Barrier Research on Atopic Dermatitis |
|
|
SciBase receives initial order for clinical study from Castle Biosciences |
|
|
Main owners strengthen their position in SciBase |
|
|
New Clinical Publication in Karger Dermatology Confirms Reader Studies as Key to Validating Nevisense |
|
|
Interim report |
|
|
SciBase announces outcome in directed share issue |
|
|
SciBase Launches Nevisense Pilot at Leading University in Southeast Florida |
|
|
A new important customer in the US, Palm Beach Dermatology Group, has placed an initial order for 6 Nevisense. |
|
|
SciBase announces outcome in directed share issue |
|
|
SciBase resolves on a directed share issue of approximately SEK 11 million |
